New Delhi, July 22 -- Experts have hinted that the proposed US decision of tariffs on generic drugs in the pharmaceutical sector is "out of scope" after US President Donald Trump made the announcement on Wednesday (local time).

Speaking to ANI on Trump's tariff announcement on generic drugs, Chairman, Pharmexcil, Namit Joshi said, "The announcement made by Trump is that there will be zero tariff for two years. 100% in the third year and 200% from the fourth year. As per our thinking, it does not seem that it will be possible so soon. Because it takes a minimum of 4-5 years to create any pharmaceutical generic ecosystem. So, if you impose a tariff in two years without creating the ecosystem, then this possibility seems very low...the Indi...